Skip to main content
Top
Published in: Abdominal Radiology 3/2018

01-03-2018

Does intravoxel incoherent motion reliably stage hepatic fibrosis, steatosis, and inflammation?

Authors: Kumaresan Sandrasegaran, Paul Territo, Reem M. Elkady, Yuning Lin, Pauley Gasparis, Gitasree Borthakur, Chen Lin

Published in: Abdominal Radiology | Issue 3/2018

Login to get access

Abstract

Objective

To investigate the usefulness of intravoxel incoherent motion (IVIM) in determining the severity of hepatic fibrosis, steatosis, and inflammation in patients with chronic liver disease.

Methods

Forty-nine patients who had liver MRI with IVIM sequence and liver biopsy within three months of MRI were enrolled. A reviewer, blinded to histology, placed regions of interest of 1–2 cm2 in the right liver lobe. In addition, the first twenty patients were assessed with a second reviewer. Perfusion fraction (f), pseudodiffusion coefficient (D fast), true diffusion coefficient (D slow), and apparent diffusion coefficient (ADC) were calculated from normalized signal intensities that were fitted into a biexponential model. Errors in the model were minimized with global stochastic optimization using Simulated Annealing. ANOVA with post hoc Tukey–Kramer test and multivariate generalized linear model analysis were performed, using histological findings as the gold standard.

Results

The most common etiologies for liver disease were hepatitis C and alcohol, accounting together for 76% (37/49) of patients. Low-grade fibrosis (F0, F1), hepatic steatosis, and inflammation were seen in 24% (12/49), 31% (15/49), and 29% (14/49) of patients, respectively. The interobserver correlation was poor for D fast and D slow (0.105, 0.173) and moderate for f and ADC (0.461, 0.418). ANOVA showed a strong inverse association between D fast and liver fibrosis grade (p = 0.001). A weak inverse association was seen between ADC and hepatic steatosis (p = 0.059). Multivariate general linear model revealed that the only significant association between IVIM parameters and pathological features was between D fast and fibrosis. On ROC curve analysis, D fast < 23.4 × 10−3 mm2/s had a sensitivity of 82.8% and a specificity of 64.3% in predicting high-grade fibrosis.

Conclusion

D fast has the strongest association with hepatic fibrosis but has weak interobserver correlation. IVIM parameters were not significantly associated with hepatic inflammation or steatosis.
Literature
1.
go back to reference Falize Ludivine, Guillygomarc’h Anne, Perrin Michele, et al. (2006) Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases†. Hepatology 44(2):472–477CrossRefPubMed Falize Ludivine, Guillygomarc’h Anne, Perrin Michele, et al. (2006) Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases†. Hepatology 44(2):472–477CrossRefPubMed
2.
go back to reference Marcellin P, Gane E, Buti M, et al. (2013) Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet 9(381):468–475CrossRef Marcellin P, Gane E, Buti M, et al. (2013) Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet 9(381):468–475CrossRef
3.
go back to reference Ichikawa S, Motosugi U, Morisaka H, et al. (2015) MRI-based staging of hepatic fibrosis: comparison of intravoxel incoherent motion diffusion-weighted imaging with magnetic resonance elastography. J Magn Reson Imaging 42(1):204–210CrossRefPubMed Ichikawa S, Motosugi U, Morisaka H, et al. (2015) MRI-based staging of hepatic fibrosis: comparison of intravoxel incoherent motion diffusion-weighted imaging with magnetic resonance elastography. J Magn Reson Imaging 42(1):204–210CrossRefPubMed
4.
go back to reference Watanabe H, Kanematsu M, Goshima S, et al. (2011) Staging hepatic fibrosis: comparison of gadoxetate disodium–enhanced and diffusion-weighted MR imaging—preliminary observations. Radiology 259(1):142–150CrossRefPubMed Watanabe H, Kanematsu M, Goshima S, et al. (2011) Staging hepatic fibrosis: comparison of gadoxetate disodium–enhanced and diffusion-weighted MR imaging—preliminary observations. Radiology 259(1):142–150CrossRefPubMed
5.
go back to reference Bohte AE, de Niet A, Jansen L, et al. (2014) Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and C. Eur Radiol 24(3):638–648CrossRefPubMed Bohte AE, de Niet A, Jansen L, et al. (2014) Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and C. Eur Radiol 24(3):638–648CrossRefPubMed
6.
go back to reference Haimerl M, Verloh N, Zeman F, et al. (2013) Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI. PLoS ONE 8(12):e85658CrossRefPubMedPubMedCentral Haimerl M, Verloh N, Zeman F, et al. (2013) Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI. PLoS ONE 8(12):e85658CrossRefPubMedPubMedCentral
7.
go back to reference Bakan AA, Inci E, Bakan S, Gokturk S, Cimilli T (2012) Utility of diffusion-weighted imaging in the evaluation of liver fibrosis. Eur Radiol 22(3):682–687CrossRefPubMed Bakan AA, Inci E, Bakan S, Gokturk S, Cimilli T (2012) Utility of diffusion-weighted imaging in the evaluation of liver fibrosis. Eur Radiol 22(3):682–687CrossRefPubMed
8.
go back to reference Taouli B, Tolia AJ, Losada M, et al. (2007) Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol 189(4):799–806CrossRefPubMed Taouli B, Tolia AJ, Losada M, et al. (2007) Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol 189(4):799–806CrossRefPubMed
9.
go back to reference Jajamovich GH, Calcagno C, Dyvorne HA, Rusinek H, Taouli B (2014) DCE-MRI of the liver: reconstruction of the arterial input function using a low dose pre-bolus contrast injection. PLoS ONE 9(12):e115667CrossRefPubMedPubMedCentral Jajamovich GH, Calcagno C, Dyvorne HA, Rusinek H, Taouli B (2014) DCE-MRI of the liver: reconstruction of the arterial input function using a low dose pre-bolus contrast injection. PLoS ONE 9(12):e115667CrossRefPubMedPubMedCentral
10.
go back to reference Xu PJ, Yan FH, Wang JH, Lin J, Ji Y (2009) Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis. J Magn Reson Imaging 29(2):341–349CrossRefPubMed Xu PJ, Yan FH, Wang JH, Lin J, Ji Y (2009) Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis. J Magn Reson Imaging 29(2):341–349CrossRefPubMed
11.
go back to reference Bulow R, Mensel B, Meffert P, et al. (2013) Diffusion-weighted magnetic resonance imaging for staging liver fibrosis is less reliable in the presence of fat and iron. Eur Radiol 23(5):1281–1287CrossRefPubMed Bulow R, Mensel B, Meffert P, et al. (2013) Diffusion-weighted magnetic resonance imaging for staging liver fibrosis is less reliable in the presence of fat and iron. Eur Radiol 23(5):1281–1287CrossRefPubMed
12.
go back to reference Sandrasegaran K, Akisik FM, Lin C, et al. (2009) Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. AJR Am J Roentgenol 193(6):1556–1560CrossRefPubMed Sandrasegaran K, Akisik FM, Lin C, et al. (2009) Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. AJR Am J Roentgenol 193(6):1556–1560CrossRefPubMed
13.
go back to reference Tosun M, Inan N, Sarisoy HT, et al. (2013) Diagnostic performance of conventional diffusion weighted imaging and diffusion tensor imaging for the liver fibrosis and inflammation. Eur J Radiol 82(2):203–207CrossRefPubMed Tosun M, Inan N, Sarisoy HT, et al. (2013) Diagnostic performance of conventional diffusion weighted imaging and diffusion tensor imaging for the liver fibrosis and inflammation. Eur J Radiol 82(2):203–207CrossRefPubMed
14.
go back to reference Wang QB, Zhu H, Liu HL, Zhang B (2012) Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: a meta-analysis. Hepatology 56(1):239–247CrossRefPubMed Wang QB, Zhu H, Liu HL, Zhang B (2012) Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: a meta-analysis. Hepatology 56(1):239–247CrossRefPubMed
15.
go back to reference Le Bihan DBE, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M (1986) MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 161:401–407CrossRefPubMed Le Bihan DBE, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M (1986) MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 161:401–407CrossRefPubMed
16.
go back to reference Koh DM, Collins DJ, Orton MR (2011) Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges. AJR Am J Roentgenol 196(6):1351–1361CrossRefPubMed Koh DM, Collins DJ, Orton MR (2011) Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges. AJR Am J Roentgenol 196(6):1351–1361CrossRefPubMed
17.
go back to reference Chung SR, Lee SS, Kim N, et al. (2015) Intravoxel incoherent motion MRI for liver fibrosis assessment: a pilot study. Acta Radiol 56(12):1428–1436CrossRefPubMed Chung SR, Lee SS, Kim N, et al. (2015) Intravoxel incoherent motion MRI for liver fibrosis assessment: a pilot study. Acta Radiol 56(12):1428–1436CrossRefPubMed
18.
go back to reference Franca M, Marti-Bonmati L, Alberich-Bayarri A, et al. (2017) Evaluation of fibrosis and inflammation in diffuse liver diseases using intravoxel incoherent motion diffusion-weighted MR imaging. Abdom Radiol (NY) 42(2):468–477CrossRef Franca M, Marti-Bonmati L, Alberich-Bayarri A, et al. (2017) Evaluation of fibrosis and inflammation in diffuse liver diseases using intravoxel incoherent motion diffusion-weighted MR imaging. Abdom Radiol (NY) 42(2):468–477CrossRef
19.
go back to reference Lu PX, Huang H, Yuan J, et al. (2014) Decreases in molecular diffusion, perfusion fraction and perfusion-related diffusion in fibrotic livers: a prospective clinical intravoxel incoherent motion MR imaging study. PLoS ONE 9(12):e113846CrossRefPubMedPubMedCentral Lu PX, Huang H, Yuan J, et al. (2014) Decreases in molecular diffusion, perfusion fraction and perfusion-related diffusion in fibrotic livers: a prospective clinical intravoxel incoherent motion MR imaging study. PLoS ONE 9(12):e113846CrossRefPubMedPubMedCentral
20.
go back to reference Luciani A, Vignaud A, Cavet M, et al. (2008) Liver cirrhosis: intravoxel incoherent motion MR imaging–pilot study. Radiology 249(3):891–899CrossRefPubMed Luciani A, Vignaud A, Cavet M, et al. (2008) Liver cirrhosis: intravoxel incoherent motion MR imaging–pilot study. Radiology 249(3):891–899CrossRefPubMed
21.
go back to reference Patel J, Sigmund EE, Rusinek H, et al. (2010) Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging 31(3):589–600CrossRefPubMedPubMedCentral Patel J, Sigmund EE, Rusinek H, et al. (2010) Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging 31(3):589–600CrossRefPubMedPubMedCentral
22.
go back to reference Wu CH, Ho MC, Jeng YM, et al. (2015) Assessing hepatic fibrosis: comparing the intravoxel incoherent motion in MRI with acoustic radiation force impulse imaging in US. Eur Radiol 25(12):3552–3559CrossRefPubMed Wu CH, Ho MC, Jeng YM, et al. (2015) Assessing hepatic fibrosis: comparing the intravoxel incoherent motion in MRI with acoustic radiation force impulse imaging in US. Eur Radiol 25(12):3552–3559CrossRefPubMed
23.
go back to reference Yoon JH, Lee JM, Baek JH, et al. (2014) Evaluation of hepatic fibrosis using intravoxel incoherent motion in diffusion-weighted liver MRI. J Comput Assist Tomogr 38(1):110–116CrossRefPubMed Yoon JH, Lee JM, Baek JH, et al. (2014) Evaluation of hepatic fibrosis using intravoxel incoherent motion in diffusion-weighted liver MRI. J Comput Assist Tomogr 38(1):110–116CrossRefPubMed
24.
go back to reference Goffe WL, Ferrier GD, Rogers J (1994) Global optimization of statistical functions with simulated annealing. J Econom 60(1–2):65–99CrossRef Goffe WL, Ferrier GD, Rogers J (1994) Global optimization of statistical functions with simulated annealing. J Econom 60(1–2):65–99CrossRef
25.
go back to reference Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24(2):289–293CrossRefPubMed Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24(2):289–293CrossRefPubMed
26.
go back to reference Goodman ZD (2007) Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol 47(4):598–607CrossRefPubMed Goodman ZD (2007) Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol 47(4):598–607CrossRefPubMed
27.
go back to reference Girometti R, Furlan A, Bazzocchi M, et al. (2007) Diffusion-weighted MRI in evaluating liver fibrosis: a feasibility study in cirrhotic patients. Radiol Med 112:394–408CrossRefPubMed Girometti R, Furlan A, Bazzocchi M, et al. (2007) Diffusion-weighted MRI in evaluating liver fibrosis: a feasibility study in cirrhotic patients. Radiol Med 112:394–408CrossRefPubMed
28.
go back to reference Lewin MP-RA, Boelle PY, et al. (2007) Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 46:658–665CrossRefPubMed Lewin MP-RA, Boelle PY, et al. (2007) Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 46:658–665CrossRefPubMed
29.
go back to reference Girometti RFA, Esposito G, et al. (2008) Relevance of b-values in evaluating liver fibrosis: a study in healthy and cirrhotic subjects using two single-shot spin-echo echo-planar diffusion-weighted sequences. J Magn Reson Imaging 28:411–419CrossRefPubMed Girometti RFA, Esposito G, et al. (2008) Relevance of b-values in evaluating liver fibrosis: a study in healthy and cirrhotic subjects using two single-shot spin-echo echo-planar diffusion-weighted sequences. J Magn Reson Imaging 28:411–419CrossRefPubMed
30.
go back to reference Bonekamp S, Torbenson MS, Kamel IR (2011) Diffusion-weighted magnetic resonance imaging for the staging of liver fibrosis. J Clin Gastroenterol 45(10):885–892CrossRefPubMedPubMedCentral Bonekamp S, Torbenson MS, Kamel IR (2011) Diffusion-weighted magnetic resonance imaging for the staging of liver fibrosis. J Clin Gastroenterol 45(10):885–892CrossRefPubMedPubMedCentral
31.
go back to reference Cece H, Ercan A, Yildiz S, et al. (2013) The use of DWI to assess spleen and liver quantitative ADC changes in the detection of liver fibrosis stages in chronic viral hepatitis. Eur J Radiol 82(8):e307–e312CrossRefPubMed Cece H, Ercan A, Yildiz S, et al. (2013) The use of DWI to assess spleen and liver quantitative ADC changes in the detection of liver fibrosis stages in chronic viral hepatitis. Eur J Radiol 82(8):e307–e312CrossRefPubMed
32.
go back to reference Tosun M, Inan N, Sarisoy HT, et al. (2012) Diagnostic performance of conventional diffusion weighted imaging and diffusion tensor imaging for the liver fibrosis and inflammation. Eur J Radiol 82(2):203–207CrossRefPubMed Tosun M, Inan N, Sarisoy HT, et al. (2012) Diagnostic performance of conventional diffusion weighted imaging and diffusion tensor imaging for the liver fibrosis and inflammation. Eur J Radiol 82(2):203–207CrossRefPubMed
33.
go back to reference Koinuma MOI, Hanafusa K, Shibuya H (2005) Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging 22(1):80–85CrossRefPubMed Koinuma MOI, Hanafusa K, Shibuya H (2005) Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging 22(1):80–85CrossRefPubMed
34.
go back to reference Chow AM, Gao DS, Fan SJ, et al. (2012) Liver fibrosis: an intravoxel incoherent motion (IVIM) study. J Magn Reson Imaging 36(1):159–167CrossRefPubMed Chow AM, Gao DS, Fan SJ, et al. (2012) Liver fibrosis: an intravoxel incoherent motion (IVIM) study. J Magn Reson Imaging 36(1):159–167CrossRefPubMed
35.
go back to reference Le Bihan D, Breton E, Lallemand D, et al. (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168:497–505CrossRefPubMed Le Bihan D, Breton E, Lallemand D, et al. (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168:497–505CrossRefPubMed
36.
go back to reference Zhang SX, Jia QJ, Zhang ZP, et al. (2014) Intravoxel incoherent motion MRI: emerging applications for nasopharyngeal carcinoma at the primary site. Eur Radiol 24(8):1998–2004CrossRefPubMedPubMedCentral Zhang SX, Jia QJ, Zhang ZP, et al. (2014) Intravoxel incoherent motion MRI: emerging applications for nasopharyngeal carcinoma at the primary site. Eur Radiol 24(8):1998–2004CrossRefPubMedPubMedCentral
37.
go back to reference Andreou A, Koh DM, Collins DJ, et al. (2013) Measurement reproducibility of perfusion fraction and pseudodiffusion coefficient derived by intravoxel incoherent motion diffusion-weighted MR imaging in normal liver and metastases. Eur Radiol 23(2):428–434CrossRefPubMed Andreou A, Koh DM, Collins DJ, et al. (2013) Measurement reproducibility of perfusion fraction and pseudodiffusion coefficient derived by intravoxel incoherent motion diffusion-weighted MR imaging in normal liver and metastases. Eur Radiol 23(2):428–434CrossRefPubMed
38.
go back to reference Kakite S, Dyvorne H, Besa C, et al. (2015) Hepatocellular carcinoma: short-term reproducibility of apparent diffusion coefficient and intravoxel incoherent motion parameters at 3.0T. J Magn Reson Imaging 41(1):149–156CrossRefPubMed Kakite S, Dyvorne H, Besa C, et al. (2015) Hepatocellular carcinoma: short-term reproducibility of apparent diffusion coefficient and intravoxel incoherent motion parameters at 3.0T. J Magn Reson Imaging 41(1):149–156CrossRefPubMed
39.
go back to reference Lee Y, Lee SS, Kim N, et al. (2015) Intravoxel incoherent motion diffusion-weighted MR imaging of the liver: effect of triggering methods on regional variability and measurement repeatability of quantitative parameters. Radiology 274(2):405–415CrossRefPubMed Lee Y, Lee SS, Kim N, et al. (2015) Intravoxel incoherent motion diffusion-weighted MR imaging of the liver: effect of triggering methods on regional variability and measurement repeatability of quantitative parameters. Radiology 274(2):405–415CrossRefPubMed
40.
go back to reference Li YT, Cercueil JP, Yuan J, et al. (2017) Liver intravoxel incoherent motion (IVIM) magnetic resonance imaging: a comprehensive review of published data on normal values and applications for fibrosis and tumor evaluation. Quant Imaging Med Surg 7(1):59–78CrossRefPubMedPubMedCentral Li YT, Cercueil JP, Yuan J, et al. (2017) Liver intravoxel incoherent motion (IVIM) magnetic resonance imaging: a comprehensive review of published data on normal values and applications for fibrosis and tumor evaluation. Quant Imaging Med Surg 7(1):59–78CrossRefPubMedPubMedCentral
41.
go back to reference Hansmann J, Hernando D, Reeder SB (2013) Fat confounds the observed apparent diffusion coefficient in patients with hepatic steatosis. Magn Reson Med 69(2):545–552CrossRefPubMed Hansmann J, Hernando D, Reeder SB (2013) Fat confounds the observed apparent diffusion coefficient in patients with hepatic steatosis. Magn Reson Med 69(2):545–552CrossRefPubMed
42.
go back to reference Poyraz AK, Onur MR, Kocakoc E, Ogur E (2012) Diffusion-weighted MRI of fatty liver. J Magn Reson Imaging 35(5):1108–1111CrossRefPubMed Poyraz AK, Onur MR, Kocakoc E, Ogur E (2012) Diffusion-weighted MRI of fatty liver. J Magn Reson Imaging 35(5):1108–1111CrossRefPubMed
43.
go back to reference Leporq B, Saint-Jalmes H, Rabrait C, et al. (2015) Optimization of intra-voxel incoherent motion imaging at 3.0 Tesla for fast liver examination. J Magn Reson Imaging 41(5):1209–1217CrossRefPubMed Leporq B, Saint-Jalmes H, Rabrait C, et al. (2015) Optimization of intra-voxel incoherent motion imaging at 3.0 Tesla for fast liver examination. J Magn Reson Imaging 41(5):1209–1217CrossRefPubMed
Metadata
Title
Does intravoxel incoherent motion reliably stage hepatic fibrosis, steatosis, and inflammation?
Authors
Kumaresan Sandrasegaran
Paul Territo
Reem M. Elkady
Yuning Lin
Pauley Gasparis
Gitasree Borthakur
Chen Lin
Publication date
01-03-2018
Publisher
Springer US
Published in
Abdominal Radiology / Issue 3/2018
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1263-8

Other articles of this Issue 3/2018

Abdominal Radiology 3/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.